Prophylaxis of Cancer
Adair, F.E.
Bulletin of the new York Academy of Medicine 23(7): 383-393
1947
ISSN/ISBN: 0028-7091 PMID: 19312539 Accession: 055232295
PDF emailed within 1 workday: $29.90
Related References
Garrone, G. 1965: Theoretical Prophylaxis and Planned Prophylaxis of Cancer of the Uterus Minerva Medica 56: 69-73Ramsey, S.; Liu, Z.; Boer, R.; Malin, J.; Sullivan, S.; Doan, Q.; Dubois, R.; Lyman, G. 2007: Pcn9 Primary Prophylaxis of Febrile Neutropenia with Pegfilgrastim Is Cost-Effective Compared with Secondary Prophylaxis for Women with Earlystage Breast Cancer Receiving ChemoTherapy Value in Health 10(3): A125-A126
Naeim, A.; Henk, H.J.; Becker, L.; Chia, V.; Badre, S.; Li, X.; Deeter, R. 2013: Pegfilgrastim prophylaxis is associated with a lower risk of hospitalization of cancer patients than filgrastim prophylaxis: a retrospective United States claims analysis of granulocyte colony-stimulating factors (G-CSF) Bmc Cancer 13: 11
Von Ardenne, M. 1971: Cancer and the bodys cancer defense regularity and mechanisms of nonspecific cancer defense as an indicator for cancer prophylaxis and optimization of immunological attacks in the area of cancer multistep therapy Naturwissenschaftliche Rundschau 24(12): 520-524
Rotstein, C.; Bow, E.J.; Laverdiere, M.; Ioannou, S.; Carr, D.; Moghaddam, N. 1999: Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. the Canadian Fluconazole Prophylaxis Study Group Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 28(2): 331-340
Geroulanos, S.; Oxelbark, S.; Turina, M. 1986: Perioperative antimicrobial prophylaxis in cardiovascular surgery. A prospective randomized trial comparing two day cefuroxime prophylaxis with four day cefazolin prophylaxis Journal of Cardiovascular Surgery 27(3): 300-306
Abis, G.S.A.; Oosterling, S.J.; Stockmann, H.B.A.C.; van der Bij, G.J.; van Egmond, M.; Vandenbroucke-Grauls, C.M.J.E.; Bonjer, H.J. 2014: Perioperative selective decontamination of the digestive tract and standard antibiotic prophylaxis versus standard antibiotic prophylaxis alone in elective colorectal cancer patients Danish Medical Journal 61(4): A4695
Kobayashi, M.; Mohri, Y.; Tonouchi, H.; Miki, C.; Nakai, K.; Kusunoki, M. 2007: Randomized clinical trial comparing intravenous antimicrobial prophylaxis alone with oral and intravenous antimicrobial prophylaxis for the prevention of a surgical site infection in colorectal cancer surgery Surgery Today 37(5): 383-388
Uchida, T.; Egawa, S.; Iwamura, M.; Ohkawa, A.; Endo, T.; Koshiba, K. 1997: Three-day intravesical instillation of anti-cancer drugs for prophylaxis of bladder cancer Oncology Reports 4(3): 573-577
Mathé, G. 1989: Lessons from past experience in cancer immunotherapy and their application to cancer and AIDS treatment and prophylaxis Biomedicine and PharmacoTherapy 43(8): 551-561
Bercow, A.S.; Eisenhauer, E.L. 2019: Screening and surgical prophylaxis for hereditary cancer syndromes with high risk of endometrial and ovarian cancer Journal of Surgical Oncology 120(5): 864-872
Biggs, K.; O'Sullivan, M.; Palmer, C.; McLellan, J.; Marple-Clark, F.; Spinks, A.; Langton-Lockton, J.; Thng, C. 2020: Post-exposure prophylaxis in the era of pre-exposure prophylaxis: a study of post-exposure prophylaxis use in South-East Queensland since the Pharmaceutical Benefits Scheme listing of pre-exposure prophylaxis International Journal of Std and Aids 31(5): 426-431
Hong, Y.; Zhang, Y.; Xiang, Y.; Ye, Z.; Lu, X. 2021: Incidence of venous thromboembolism and hemorrhage in Chinese patients after pulmonary lobectomy: mechanical prophylaxis or mechanical prophylaxis combined with pharmacological prophylaxis: a randomized controlled trial Annals of Translational Medicine 9(18): 1478
Audier, A.G. 1957: An immunological approach to cancer therapy and cancer prophylaxis Acta Leidensia 26: 5-10
Adolphs, H.D.; Bastian, H.P. 1986: Chemoimmunprophylaxe beim oberflächlichen Harnblasenkarzinom - Chimioimmunoprophylaxie dans le cancer superficiel de la vessie - Chemoimmune prophylaxis of superficial bladder cancer der Urologe. Ausgabe a 25(1): 51-54
T K, B.S.G. 2012: Maternal HIV-1 Disease Progression 18―24 Months Postdelivery According to Antiretroviral Prophylaxis Regimen (Triple-Antiretroviral Prophylaxis During Pregnancy and Breastfeeding vs Zidovudine/Single-Dose Nevirapine Prophylaxis): The Kesho Bora Randomized Controlled Trial Clinical Infectious Diseases 55(3): 449-460
Dioulasso, B.; Faso, B.; Meda, N.; Fao, P.; Ky-Zerbo, O.; Gouem, C.; Somda, P.; Hien, H.é; Ouedraogo, P.E.ée.; Kania, D.; Sanou, A.; Kossiwavi, I.A.; Sanogo, B.; Ouedraogo, M.; Siribie, I.; Valéa, D.; Ouedraogo, S.; Somé, R.; Rouet, F.ço.; Rollins, N.; McFetridge, L.; Naidu, K.; Luchters, S.; Reyners, M.; Irungu, E.; Katingima, C.; Mwaura, M.; Ouattara, G.; Mandaliya, K.; Wambua, S.; Thiongo, M.; Nduati, R.; Kose, J.; Njagi, E.; Mwaura, P.; Newell, M.-L.; Mepham, S.; Viljoen, J.; Bland, R.; Mthethwa, L. 2012: Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs zidovudine/single-dose nevirapine prophylaxis): the Kesho Bora randomized controlled trial Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 55(3): 449-460
Kalka, C.; Spirk, D.; Siebenrock, K.-A.; Metzger, U.; Tuor, P.; Sterzing, D.; Oehy, K.; Wondberg, D.; Mouhsine, E.Y.; Gautier, E.; Kucher, N. 2009: Lack of extended venous thromboembolism prophylaxis in high-risk patients undergoing major orthopaedic or major cancer surgery. Electronic Assessment of VTE Prophylaxis in High-Risk Surgical Patients at Discharge from Swiss Hospitals (ESSENTIAL) Thrombosis and Haemostasis 102(1): 56-61
Vanbaelen, T.; Rotsaert, A.; Jacobs, B.K.M.; Florence, E.; Kenyon, C.; Vuylsteke, B.; Laga, M.; Thijs, R. 2022: Why do HIV Pre-Exposure Prophylaxis Users Discontinue Pre-Exposure Prophylaxis Care? a Mixed Methods Survey in a Pre-Exposure Prophylaxis Clinic in Belgium Aids Patient Care and Stds 36(4): 159-167
Seki, J.T.; Vather, T.; Atenafu, E.G.; Kukreti, V.; Krzyzanowska, M.K. 2014: Bridging efforts to longitudinally improve and evaluate VEnous thromboembolism prophylaxis uptake in hospitalized cancer patients through Interprofessional Teamwork (BELIEVE IT): a study by Princess Margaret Cancer Centre Thrombosis Research 133(1): 34-41